ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ITX Itaconix Plc

153.00
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Itaconix Plc LSE:ITX London Ordinary Share GB00BPK3YZ68 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 153.00 146.00 160.00 153.00 148.00 153.00 536 08:00:26
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Chemicals & Chem Preps, Nec 5.6M -2.46M -0.1826 -8.38 20.63M
Itaconix Plc is listed in the Chemicals & Chem Preps sector of the London Stock Exchange with ticker ITX. The last closing price for Itaconix was 153p. Over the last year, Itaconix shares have traded in a share price range of 114.00p to 276.00p.

Itaconix currently has 13,486,122 shares in issue. The market capitalisation of Itaconix is £20.63 million. Itaconix has a price to earnings ratio (PE ratio) of -8.38.

Itaconix Share Discussion Threads

Showing 2676 to 2698 of 10650 messages
Chat Pages: Latest  114  113  112  111  110  109  108  107  106  105  104  103  Older
DateSubjectAuthorDiscuss
20/10/2019
14:17
Pug - have said this before. We have enough cash till april/ May as costs have come down a lot over last one year and we continue to increase revenue.Yes we may raise funds early next year( possibly January/february) but imo will be higher than today's share price.
jungmana
20/10/2019
14:07
Jungman- Subject of course that they do not need further funding and that the pipeline delivers -

Do you agree with the cash burn calculations in 2242 above? These are as you can see based on both Proactives forecasts and the latest rns? if not why not.

pugugly
20/10/2019
13:40
for new investors good research piece by Proactive. as noted there itx is undervalued compared to peers in the speciality chemicals industry;

"We argue that the market values these types of companies relative to
their addressable market size, rather than on a one-year or two-year
forward revenue multiple. On this basis, we believe that the current
valuation of Itaconix leaves significant upside."

jungmana
20/10/2019
13:02
But with a potential cash call comjng
rhatton
20/10/2019
12:47
So unless my maths is out the eqivalent share price now would be about 5.9p?
ivor hunch
20/10/2019
11:25
Exactly 2 years ago itx was trading about 20p and had roughly 80m shares in issue ( about GBP 16m market cap).The company has taken huge leaps forward since 2017 with end of research and development phase, trimming of business, reduction in costs And signing partnerships with 3 big majors.But now sitting at 1.6p with about 270m shares in issue (about GBP 4.5m market cap).Excellent investment opportunity at this level imo
jungmana
20/10/2019
10:38
31m invested in development all secured with 42 granted patents. All IP available for a little over 4m.Itaconix are the world leader in bio-based polymers from itaconic acid. Combining the versatile chemistry of itaconic acid with breakthrough economics, we are establishing a pipeline of polymers that compete on unique functionality and cost advantages in home care, industrial markets and personal care.From Pfizer in the 1960's to Rohm & Haas in the 1990's, leading polymer chemists have recognized the potential of polyitaconates with the functionality of its two distinct carboxylic acid groups but have been unable to identify an economic manufacturing process.The 2004 US Department of Energy Bio-Based Chemical Report highlighted itaconic acid as one of the top 12 value added chemicals from biomass, and identified its polymerization as the key barrier to commercial success.Itaconix have developed a process with breakthrough economics and low capital investment. Using its ability to produce itaconic acid polymers at competitive costs, Itaconix is developing a growing line of high-value products through the use and modification of the unique acid groups to achieve desired properties that meet specific customer or market needs.
lukehold
19/10/2019
17:51
dex, ideally Wednesday
the patient investor
19/10/2019
14:39
Gets a mention in the Daily Mail's Stockwatch.Summary of news yesterday with a coloured chart and of course Neil W.
geraldus
19/10/2019
14:33
TPI, I hope you're not hoping to retire any time soon then....
dexdringle
19/10/2019
14:17
Sorry 40million market cap at DCTA
wololol
19/10/2019
14:16
I think Investors as well need to look at other companies with similar IP and their valuations. Directa Plus 60million market cap and still not in profit. There are several others as well. Where is the info about 31 million Luke I'd be interested to research that more. I think we are going to have a strong rally soon especially after seeing the demand on Friday. Great recovery and grewl entry point for new investors . I think true value is around 5p at the moment.
wololol
19/10/2019
13:42
itx is my retirement fund ;-)
the patient investor
19/10/2019
12:42
Doubled holding on dip yesterday. 31m investment in developing and getting patented, in demand products to market. Rewards just starting to take shape, all available for 4.3m
lukehold
18/10/2019
17:22
Yay, that's what I wanted to see - a big after-hours trade! 1.5M there. Let's hope we get an RNS on Monday saying that Spreadex are out, or that it's a director buy?NAI
cyberbub
18/10/2019
13:25
Thanks for the latest vid.Look forward to achieving critical mass.
geraldus
18/10/2019
13:09
Yes thanks for posting
value viper
18/10/2019
11:47
Brilliant, thx parob
the patient investor
18/10/2019
11:37
Video interview with John Shaw just out.Polymers specialist Itaconix 'accelerating' revenue post trading update2019-10-18 11:13:00hTTps://tinyurl.com/y426vuq2Polymers specialist Itaconix (LON:ITX) tells Proactive London it will accelerate "key revenue opportunities" on the back of its figures announcement today. CEO John Shaw acknowledges Itaconix's full-year sales are below current market expectations but explains this is due to fast company growth and larger projects being delayed. Turnover for the first three quarters of the year was £700,000, up 78% on the comparable period last year. Revenues in the second half will be higher than the first six months.
parob
18/10/2019
10:49
very good point rivaldo, i still see blue today
the patient investor
18/10/2019
10:27
Funnily enough today's news could do us a big favour. The fall has brought in decent buying interest which will have cleared the Spreadex overhang that much more quickly than otherwise.

If and when positive news is announced, then with a mere £4m m/cap and not many shares available the price reaction would be interesting.

rivaldo
18/10/2019
10:03
This is a disappointing update IMO. At least the market doesn't seem to have taken it too hard though... So far.Let's hope for more sales growth soon. At least it's good that they are giving us more regular updates.What we could do with now is the directors buying another few mill to show confidence.
cyberbub
18/10/2019
09:43
can we have 2p please
the patient investor
Chat Pages: Latest  114  113  112  111  110  109  108  107  106  105  104  103  Older

Your Recent History

Delayed Upgrade Clock